GLYCOTEST
Glycotest Diagnostics is developing unique and non-invasive blood tests for the large populations at risk of developing liver cancers and fibrosis-cirrhosis. Our technology could revolutionize care and treatment for groups at risk due to chronic liver disease—both people with viral hepatitis (chronic hepatitis B and C infections) and the rapidly growing population with non-viral hepatitis due to obesity and metabolic disease. Over 25 million people in the US, 800 million worldwide, and another 1.2 billion in jeopardy due to fatty liver disease may benefit from Glycotest’s products.
GLYCOTEST
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2012-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.glycotest.com
Total Employee:
11+
Status:
Active
Contact:
+1 484 431 3483
Email Addresses:
[email protected]
Total Funding:
10 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt WordPress Font Awesome Wordpress Plugins Mobile Non Scaleable Content Nginx
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Fosun Pharma
Fosun Pharma investment in Series A - Glycotest
Official Site Inspections
http://www.glycotest.com Semrush global rank: 2.26 M Semrush visits lastest month: 8.42 K
- Host name: 125.81.214.35.bc.googleusercontent.com
- IP address: 35.214.81.125
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
